Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER, ORA To Be Major Beneficiaries Of Speedier FDA Hiring Process

Executive Summary

As Congress debates increased funding and other steps to improve FDA oversight of imported drugs, the agency plans to hire 1,317 people in the next six months to bring staff numbers up to their full authorized levels

You may also be interested in...



FDA Hiring Challenges Help Drive Commissioner Hamburg's Reorganization

FDA's troubled interaction with the HHS personnel system is driving some of the restructuring that Commissioner Margaret Hamburg has proposed for her office

FDA Hiring Challenges Help Drive Commissioner Hamburg's Reorganization

FDA's troubled interaction with the HHS personnel system is driving some of the restructuring that Commissioner Margaret Hamburg has proposed for her office

PhRMA Wants FDA To Explain When Decisions Depart From Committee Votes

FDA should explain the why of its important regulatory decisions in consumer-friendly language, according to the Pharmaceutical Research and Manufacturers of America

Related Content

UsernamePublicRestriction

Register

PS049574

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel